Literature DB >> 15159019

Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles.

D Patrick O'Neal1, Leon R Hirsch, Naomi J Halas, J Donald Payne, Jennifer L West.   

Abstract

The following study examines the feasibility of nanoshell-assisted photo-thermal therapy (NAPT). This technique takes advantage of the strong near infrared (NIR) absorption of nanoshells, a new class of gold nanoparticles with tunable optical absorptivities that can undergo passive extravasation from the abnormal tumor vasculature due to their nanoscale size. Tumors were grown in immune-competent mice by subcutaneous injection of murine colon carcinoma cells (CT26.WT). Polyethylene glycol (PEG) coated nanoshells (approximately 130 nm diameter) with peak optical absorption in the NIR were intravenously injected and allowed to circulate for 6 h. Tumors were then illuminated with a diode laser (808 nm, 4 W/cm2, 3 min). All such treated tumors abated and treated mice appeared healthy and tumor free >90 days later. Control animals and additional sham-treatment animals (laser treatment without nanoshell injection) were euthanized when tumors grew to a predetermined size, which occurred 6-19 days post-treatment. This simple, non-invasive procedure shows great promise as a technique for selective photo-thermal tumor ablation. Copyright 2004 Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15159019     DOI: 10.1016/j.canlet.2004.02.004

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  346 in total

1.  Closed-Loop Intravenous Drug Administration Using Photoplethysmography.

Authors:  George W Carpenter; Holly G Myers; Eric A Sherer; Katie A Evans; D Patrick O'Neal
Journal:  IEEE J Transl Eng Health Med       Date:  2018-11-01       Impact factor: 3.316

2.  Generation and detection of plasmonic nanobubbles in zebrafish.

Authors:  E Y Lukianova-Hleb; C Santiago; D S Wagner; J H Hafner; D O Lapotko
Journal:  Nanotechnology       Date:  2010-05-07       Impact factor: 3.874

3.  Synthesis and surface functionalization of silica nanoparticles for nanomedicine.

Authors:  Alexander Liberman; Natalie Mendez; William C Trogler; Andrew C Kummel
Journal:  Surf Sci Rep       Date:  2014-09       Impact factor: 12.267

4.  Anisotropic nanomaterials: structure, growth, assembly, and functions.

Authors:  Panikkanvalappil R Sajanlal; Theruvakkattil S Sreeprasad; Akshaya K Samal; Thalappil Pradeep
Journal:  Nano Rev       Date:  2011-02-16

5.  Characterization of bionanocomposite scaffolds comprised of mercaptoethylamine-functionalized gold nanoparticles crosslinked to acellular porcine tissue.

Authors:  Corey R Deeken; Sharon L Bachman; Bruce J Ramshaw; Sheila A Grant
Journal:  J Mater Sci Mater Med       Date:  2011-11-10       Impact factor: 3.896

6.  Chemosensitization of cancer cells via gold nanoparticle-induced cell cycle regulation.

Authors:  Megan A Mackey; Mostafa A El-Sayed
Journal:  Photochem Photobiol       Date:  2014-02-11       Impact factor: 3.421

7.  Comparison study of gold nanohexapods, nanorods, and nanocages for photothermal cancer treatment.

Authors:  Yucai Wang; Kvar C L Black; Hannah Luehmann; Weiyang Li; Yu Zhang; Xin Cai; Dehui Wan; Si-Yun Liu; Max Li; Paul Kim; Zhi-Yuan Li; Lihong V Wang; Yongjian Liu; Younan Xia
Journal:  ACS Nano       Date:  2013-02-12       Impact factor: 15.881

8.  Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications.

Authors:  Jonathan O Martinez; Brandon S Brown; Nicoletta Quattrocchi; Michael Evangelopoulos; Mauro Ferrari; Ennio Tasciotti
Journal:  Chin Sci Bull       Date:  2012-11-01

9.  Engineering of hetero-functional gold nanorods for the in vivo molecular targeting of breast cancer cells.

Authors:  Mohammad Eghtedari; Anton V Liopo; John A Copland; Alexander A Oraevsky; Massoud Motamedi
Journal:  Nano Lett       Date:  2009-01       Impact factor: 11.189

Review 10.  Nanotechnologies for noninvasive measurement of drug release.

Authors:  Thomas Moore; Hongyu Chen; Rachel Morrison; Fenglin Wang; Jeffrey N Anker; Frank Alexis
Journal:  Mol Pharm       Date:  2013-11-26       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.